LDL Receptor and ApoE Are Involved in the Clearance of ApoM-associated Sphingosine 1-Phosphate

Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M

(2013) Makoto Kurano et al.   ATHEROSCLEROSIS

Plasma Sphingosine-1-Phosphate Is Elevated in Obesity

(2013) Greg M. Kowalski et al.   PLoS One

Targeting HDL-cholesterol to reduce residual cardiovascular risk

(2012) Alma O. Iacob et al.   CURRENT OPINION IN LIPIDOLOGY

Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver

(2012) Makoto Kurano et al.   JOURNAL OF LIPID RESEARCH

The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles

(2012) Christina Christoffersen et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo

(2011) Corina Rosales et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

(2011) Uchechukwu K. Sampson et al.   Current Atherosclerosis Reports

The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease

(2011) H. Bryan Brewer   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

(2011) Kelley M Argraves et al.   Lipids in Health and Disease

LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL

(2011) Makoto Kurano et al.   Lipids in Health and Disease

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

(2011) C. Christoffersen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

(2010) Paul J.W.H. Kappelle et al.   ATHEROSCLEROSIS

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

(2010) Katherine J. E. Sattler et al.   BASIC RESEARCH IN CARDIOLOGY

Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B–Containing Lipoproteins and Atherosclerosis

(2010) Christina Christoffersen et al.   CIRCULATION RESEARCH

Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters

(2008) R. Ohkawa et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Plasma sphingosine 1-phosphate metabolism and analysis

(2007) Yutaka Yatomi   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS